Versor Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-405,945
Closed -$16M 877
2023
Q2
$16M Buy
+405,945
New +$14.3M 2.77% 7

Versor Investments's ISEE Position: Q3 2023 in Review

Versor Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 405,945 shares — an estimated $16M sold.

Versor Investments first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $16M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Versor Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Versor Investments sold 405,945 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $16M.
  • Versor Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Versor Investments's IVERIC bio, Inc. Common Stock position peaked at $16M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Versor Investments's 13F filing for Q3 2023, filed 6 Nov 2023.